Glenmark Pharmaceuticals Inc. has been granted final approval by the US FDA for HAILEYTM Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/20 mcg and Ferrous Fumarate Tablets), the generic version of Loestrin Fe 1/20 tablets, of Allergan Pharmaceuticals International Limited.

Glenmark’s current portfolio consists of 129 products authorized for distribution in the US marketplace and 58 ANDA’s pending approval. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.


10 Diagnostic Imaging Trends for 2018

Best of 2017 Medical

 

Digital version